Welcome to our dedicated page for Kindly Md SEC filings (Ticker: NAKA), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Kindly Md's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Kindly Md's regulatory disclosures and financial reporting.
Mark W. Yusko, a director of Kindly MD, Inc. (NAKA), reports direct beneficial ownership of 2,100,000 shares of the company's common stock. The filing is an initial disclosure of ownership under Section 16, showing the director holds the shares directly rather than through an indirect vehicle. The statement documents ownership but does not disclose any derivative holdings or changes in compensation or transactions.
Kindly MD, a Utah-based healthcare company focused on hospitals and physicians, has filed Form D for an exempt securities offering under Rule 506(b). The company has successfully completed a $711.7 million offering, with the entire amount already sold to 156 investors.
Key details of the offering include:
- Sales commissions of $20.6 million and finder's fees of $293,400
- Cohen & Company Capital Markets and Anthem Securities LLC serving as brokers, receiving equity fees of 2% and 0.5% respectively of post-closing common stock
- Offering includes equity, debt, and options/warrants
- Connected to a business combination transaction (merger/acquisition)
The company's leadership includes Timothy Pickett as CEO and Director, with other executives Jared Barrera and Adam Cox. The board includes Amy Powell, Christian Robinson, and Gary Seelhorst. The offering was marketed across multiple states including California, New York, Texas, and international markets.
KindlyMD (NASDAQ:NAKA) filed an 8-K announcing the appointment of Andrew Creighton as Chief Commercial Officer of Nakamoto Holdings. The filing indicates this is a Regulation FD disclosure, with the information being furnished rather than filed under Section 18 of the Securities Exchange Act. The company, which is classified as an emerging growth company, made this announcement via press release on June 25, 2025.
FAQ
What is the current stock price of Kindly Md (NAKA)?
What is the market cap of Kindly Md (NAKA)?
